Chronic myeloid leukemia: the basis of treatment for tomorrow
Date
2011
Authors
Carella, A.M.
Goldman, J.M.
Martinelli, G.
Melo, J.V.
Perrotti, D.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Haematologica: the hematology journal, 2011; 96(12):1737-1739
Statement of Responsibility
Angelo M. Carella, John M. Goldman, Giovanni Martinelli, Junia V. Melo, Danilo Perrotti
Conference Name
Abstract
Recent years have seen dramatic advances in deciphering the molecular pathogenesis of chronic myeloid leukemia (CML). This has resulted in the rapid development of many BCR-ABL1-specific tyrosine kinase inhibitors (TKI) which have improved 10-year survival to more than 80%. In this paper we focus on some future directions for CML biology and therapy.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright © Ferrata Storti Foundation